Intake of Po-210 into the body through the damaged skin and efficiency of some methods in preventing its absorption.
D000476:Alkanesulfonates / Q000627:therapeutic use; D000818:Animals; D002614:Chelating Agents / Q000627:therapeutic use; D062109:Dermatologic Surgical Procedures; D007668:Kidney / Q000378:metabolism; D009132:Muscles / Q000293:injuries; D011059:Polonium / Q000378:metabolism*; D051381:Rats; D012867:Skin / Q000293:injuries*; D012869:Skin Absorption; D013154:Spleen / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D014950:Wounds, Penetrating / Q000378:metabolism / Q000601:surgery
D000476:Alkanesulfonates; D002614:Chelating Agents; D013438:Sulfhydryl Compounds; D011059:Polonium